Fresenius Medical Care AG & Co. KGaA (FMS) Stock

Fresenius Medical Care AG & Co. KGaA, headquartered in Bad Homburg, Germany, is a global leader in providing dialysis care and related services across Germany, North America, and other international markets. Established in 1996, the company operates a vast network of outpatient dialysis clinics where it delivers essential dialysis treatment alongside laboratory and diagnostic services. These clinics serve as crucial hubs for patient care, offering comprehensive support including clinical monitoring, supply delivery to patients' homes, and follow-up assistance.

In addition to its outpatient services, Fresenius Medical Care AG & Co. KGaA provides contracted dialysis services to hospitals in the United States, catering to end-stage renal disease (ESRD) patients and those experiencing acute kidney failure. The company is also prominent in the development, manufacturing, and distribution of a wide range of dialysis products, encompassing dialyzers, hemodialysis machines, peritoneal dialysis cyclers, dialysis solutions, concentrates, and renal pharmaceuticals. Beyond dialysis, Fresenius Medical Care AG & Co. KGaA offers acute cardiopulmonary and apheresis products, reinforcing its commitment to comprehensive healthcare solutions.

With a global presence spanning approximately 150 countries and operating over 4,171 outpatient dialysis clinics as of February 2022, Fresenius Medical Care AG & Co. KGaA serves a diverse customer base that includes dialysis clinics, hospitals, and specialized treatment centers. The company's extensive product offerings are distributed through direct sales channels, local sales forces, independent distributors, and dealers, ensuring broad accessibility to its life-saving treatments and medical products worldwide.